H

Hana Pharm Co Ltd
KRX:293480

Watchlist Manager
Hana Pharm Co Ltd
KRX:293480
Watchlist
Price: 11 010 KRW 0.82% Market Closed
Market Cap: 190.5B KRW
Have any thoughts about
Hana Pharm Co Ltd?
Write Note

Operating Margin
Hana Pharm Co Ltd

9.8%
Current
15%
Average
6.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
9.8%
=
Operating Profit
22.1B
/
Revenue
225.2B

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
KR
Hana Pharm Co Ltd
KRX:293480
190.5B KRW
10%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-83%
US
Eli Lilly and Co
NYSE:LLY
729.3B USD
35%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
DK
Novo Nordisk A/S
CSE:NOVO B
2.9T DKK
44%
US
Johnson & Johnson
NYSE:JNJ
347.8B USD
28%
US
Merck & Co Inc
NYSE:MRK
248.3B USD
34%
CH
Roche Holding AG
SIX:ROG
197B CHF
32%
UK
AstraZeneca PLC
LSE:AZN
160.1B GBP
21%
CH
Novartis AG
SIX:NOVN
169.8B CHF
31%
US
Pfizer Inc
NYSE:PFE
149.4B USD
22%
Country KR
Market Cap 190.5B KRW
Operating Margin
10%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 729.3B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 2.9T DKK
Operating Margin
44%
Country US
Market Cap 347.8B USD
Operating Margin
28%
Country US
Market Cap 248.3B USD
Operating Margin
34%
Country CH
Market Cap 197B CHF
Operating Margin
32%
Country UK
Market Cap 160.1B GBP
Operating Margin
21%
Country CH
Market Cap 169.8B CHF
Operating Margin
31%
Country US
Market Cap 149.4B USD
Operating Margin
22%
No Stocks Found

Hana Pharm Co Ltd
Glance View

Market Cap
190.5B KRW
Industry
Pharmaceuticals

Hana Pharm Co., Ltd. engages in the research, development, and manufacture of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do and currently employs 657 full-time employees. The company went IPO on 2018-10-02. The company’s main products include cardiovascular drugs involves hypertension and hyperlipidemia medicines, as well as blood circulation improvement drugs; analgesics for severe pain and anesthetics for surgery and sedation; as well as gastrointestinal drugs such as peptic ulcer treatment and antispasmodics. The firm also provides antibiotics, dermatology analgesics, antipyretics and anti-inflammatory drugs.

Intrinsic Value
18 041.77 KRW
Undervaluation 39%
Intrinsic Value
Price
H

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
9.8%
=
Operating Profit
22.1B
/
Revenue
225.2B
What is the Operating Margin of Hana Pharm Co Ltd?

Based on Hana Pharm Co Ltd's most recent financial statements, the company has Operating Margin of 9.8%.